Real-world application of CGM use in patients who are treated with basal insulin: a patient case study
Released On
August 30, 2024
Expires On
August 16, 2025
Media Type
Internet
Completion Time
15 minutes
Specialty
Primary Care
Topic(s)
Diabetes, T2D
This activity is supported by an educational grant from Abbott.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This program is aimed at US-based primary care physicians who are looking to improve their knowledge and skills in CGM technology for patients with T2D.
Program Overview
This comprehensive educational program includes CME-accredited interactive case studies which focuses on clinical reasoning and decision-making skills, and patient communication and education. In addition, the CME-accredited patient-provider interview showcases optimal shared decision-making techniques guiding patient care with CGM devices.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify patients who are appropriate candidates for CGM devices
- Compare available CGM technologies based on individual patient characteristics
- Adapt clinical decision-making using patients’ CGM device readouts
- Apply shared decision-making tools when evaluating barriers to CGM usage and adherence
- Modify patient education techniques for utilization in time-limited primary care appointments
Faculty
Vivian Fonseca, MD, FRCP
Tulane University School of Medicine, New Orleans, LA
Dr. Fonseca is Professor of Medicine, Assistant Dean for Clinical Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is a Past President for Science and Medicine of the American Diabetes Association (2012) and has served on the ADA Board of Directors and several committees. He has served on the Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the Board of Trustees of the American College of Endocrinology. He has served on committees writing guidelines for both organizations. He has held a leadership role and served on various committees in several other organizations including the American Board of Internal Medicine. He has received several awards including Banting Medal for Leadership and Service from The American Diabetes Association, the Seale – Harris award from the Southern Medical Association, and the Gerald Reaven award from the World Congress in Insulin Resistance. He has received several teaching awards and was elected to the Alpha Omega Alpha Honor Medical Society and has been listed for several years among the Best Doctors in the USA and for several years rated by Expertscape among the top 10 experts in Diabetes worldwide. Dr. Fonseca is a fellow of the Royal College of Physicians (London).
He plays a significant role in Clinical Research as Assistant Dean at Tulane University, and in its partnership with the Louisiana Clinical and Translational Science (LACaTS) Program. Dr Fonseca has served as Associate Director of the Aging and Cardiometabolic COBREs and a mentor and committee member in BIRCWH. He a strong interest in facilitating clinical research and developing the next generation of translational researchers. He is the Medical Director of the Tulane Clinical Trials Unit and Director of the Research Professional Development Core, which runs the Masters in Science in Clinical Research degree course.
Dr. Fonseca’s research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease, particularly on the role of inflammation and other novel risk factors. He has a research program evaluating inflammation in diabetes and using technology to improve diabetes care in underprivileged populations, especially the development and use of a novel diabetes risk engine (BRAVO) in clinical practice. He is Co – PI of REACHNET a large network that conducts research utilizing electronic health records of over 2 million people across several states. He is the site PI of several large national research programs including 1. the All of Us Program, 2. COVID related studies – N3C utilizing EMR data about COVID and the RECOVER study which will evaluate long term COVID complications in a large cohort.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
- Vivian Fonseca, MD, FRCP
- Employee/Owner: Eli Lilly, Corcept
- Consultant/Advisory Board: Asahi, Bayer, Abbott, Boehringer Ingelheim, Corcept
- Grants (paid to institution): Fractyl, Jaguar Gene Therapy
- Stockholder: Amgen, Abbott
- Stock Options: Mellitus Health, BRAVO4Health
- Patents Pending: BRAVO risk engine for predicting diabetes complications; PAX4 gene therapy for type 1 diabetes
In addition to the expert faculty, Postgraduate Institute for Medicine and Springer Healthcare IME planners and staff include Holly Keatts, Judith Mitchek, Maria Glukhovsky, Elizabeth Samander, Alessandra Geffner-Smith, and Jennifer Jett. The Planning Committee have no financial relationships to disclose.
All relevant financial relationships of the Faculty have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available for the participant.
Course Viewing Requirements
Supported Browsers
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Springer Healthcare IME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].
